High strength chondroitin sulfate has demonstrated superiority over celecoxib in reducing the progression of knee OA structural changes in an imaging study presented at ACR15. The two- year double blind trial randomised 194 people with symptomatic OA to 1200mg of chondroitin sulfate daily or 200mg of celecoxib daily. The researchers performed MRIs to detect loss ...
Clinically meaningful evidence for chondroitin in OA
12 Nov 2015